Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).
Gumustepe E, Yavas G, Kirakli EK, Dincbas FÖ, N D, Hurmuz P, Koksoy EB, Catal TK, Özler T, Yilmaz Aslan MT, Akyurek S. Gumustepe E, et al. Among authors: koksoy eb. Am J Clin Oncol. 2024 Oct 22. doi: 10.1097/COC.0000000000001152. Online ahead of print. Am J Clin Oncol. 2024. PMID: 39434398
A case of melanoma with atypical presentation.
Tezduyan Ç, Yalçiner M, Köksoy EB. Tezduyan Ç, et al. Among authors: koksoy eb. Tuberk Toraks. 2024 Sep;72(3):229-232. doi: 10.5578/tt.202403963. Tuberk Toraks. 2024. PMID: 39275935 Free article. English.
Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer.
Alkan A, Mızrak D, Yaşar A, Karcı E, Köksoy EB, Ürün M, Özyurt N, Kuştaş AA, Kütük T, Ürün Y, Şenler FÇ, Akyürek S, Utkan G, Demirkazık A, Gökçe ŞÇ, Akbulut H. Alkan A, et al. Among authors: koksoy eb. J Cancer Res Ther. 2024 Apr 1;20(3):913-917. doi: 10.4103/jcrt.jcrt_1009_20. Epub 2024 Jun 27. J Cancer Res Ther. 2024. PMID: 39023597 Free article.
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group.
Gürbüz M, Kiliçkap S, Bilici A, Karadurmuş N, Sezer A, Şendur MAN, Paydaş S, Artaç M, Fulden Yumuk P, Gürsoy P, Uysal M, Şenol Coşkun H, Tatli AM, Selçukbiricik F, Dişel U, Köksoy EB, Güven DC, Uğrakli M, Akkuş E, Yücel Ş, Erol C, Karakaya S, Şakalar T, Khanmammadov N, Paksoy N, Demirkazik A. Gürbüz M, et al. Among authors: koksoy eb. Medicine (Baltimore). 2022 Dec 16;101(50):e32368. doi: 10.1097/MD.0000000000032368. Medicine (Baltimore). 2022. PMID: 36550824 Free PMC article.
28 results